Cargando…

Covid-19 and excess mortality in medicare beneficiaries

We estimated excess mortality in Medicare recipients in the United States with probable and confirmed Covid-19 infections in the general community and amongst residents of long-term care (LTC) facilities. We considered 28,389,098 Medicare and dual-eligible recipients from one year before February 29...

Descripción completa

Detalles Bibliográficos
Autores principales: Greenwald, Scott D., Chamoun, Nassib G., Manberg, Paul J., Gray, Josh, Clain, David, Maheshwari, Kamal, Sessler, Daniel I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8809573/
https://www.ncbi.nlm.nih.gov/pubmed/35108291
http://dx.doi.org/10.1371/journal.pone.0262264
_version_ 1784644046299332608
author Greenwald, Scott D.
Chamoun, Nassib G.
Manberg, Paul J.
Gray, Josh
Clain, David
Maheshwari, Kamal
Sessler, Daniel I.
author_facet Greenwald, Scott D.
Chamoun, Nassib G.
Manberg, Paul J.
Gray, Josh
Clain, David
Maheshwari, Kamal
Sessler, Daniel I.
author_sort Greenwald, Scott D.
collection PubMed
description We estimated excess mortality in Medicare recipients in the United States with probable and confirmed Covid-19 infections in the general community and amongst residents of long-term care (LTC) facilities. We considered 28,389,098 Medicare and dual-eligible recipients from one year before February 29, 2020 through September 30, 2020, with mortality followed through November 30(th), 2020. Probable and confirmed Covid-19 diagnoses, presumably mostly symptomatic, were determined from ICD-10 codes. We developed a Risk Stratification Index (RSI) mortality model which was applied prospectively to establish baseline mortality risk. Excess deaths attributable to Covid-19 were estimated by comparing actual-to-expected deaths based on historical (2017–2019) comparisons and in closely matched concurrent (2020) cohorts with and without Covid-19. Overall, 677,100 (2.4%) beneficiaries had confirmed Covid-19 and 2,917,604 (10.3%) had probable Covid-19. A total of 472,329 confirmed cases were community living and 204,771 were in LTC. Mortality following a probable or confirmed diagnosis in the community increased from an expected incidence of about 4.0% to actual incidence of 7.5%. In long-term care facilities, the corresponding increase was from 20.3% to 24.6%. The absolute increase was therefore similar at 3–4% in the community and in LTC residents. The percentage increase was far greater in the community (89.5%) than among patients in chronic care facilities (21.1%) who had higher baseline risk of mortality. The LTC population without probable or confirmed Covid-19 diagnoses experienced 38,932 excess deaths (34.8%) compared to historical estimates. Limitations in access to Covid-19 testing and disease under-reporting in LTC patients probably were important factors, although social isolation and disruption in usual care presumably also contributed. Remarkably, there were 31,360 (5.4%) fewer deaths than expected in community dwellers without probable or confirmed Covid-19 diagnoses. Disruptions to the healthcare system and avoided medical care were thus apparently offset by other factors, representing overall benefit. The Covid-19 pandemic had marked effects on mortality, but the effects were highly context-dependent.
format Online
Article
Text
id pubmed-8809573
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-88095732022-02-03 Covid-19 and excess mortality in medicare beneficiaries Greenwald, Scott D. Chamoun, Nassib G. Manberg, Paul J. Gray, Josh Clain, David Maheshwari, Kamal Sessler, Daniel I. PLoS One Research Article We estimated excess mortality in Medicare recipients in the United States with probable and confirmed Covid-19 infections in the general community and amongst residents of long-term care (LTC) facilities. We considered 28,389,098 Medicare and dual-eligible recipients from one year before February 29, 2020 through September 30, 2020, with mortality followed through November 30(th), 2020. Probable and confirmed Covid-19 diagnoses, presumably mostly symptomatic, were determined from ICD-10 codes. We developed a Risk Stratification Index (RSI) mortality model which was applied prospectively to establish baseline mortality risk. Excess deaths attributable to Covid-19 were estimated by comparing actual-to-expected deaths based on historical (2017–2019) comparisons and in closely matched concurrent (2020) cohorts with and without Covid-19. Overall, 677,100 (2.4%) beneficiaries had confirmed Covid-19 and 2,917,604 (10.3%) had probable Covid-19. A total of 472,329 confirmed cases were community living and 204,771 were in LTC. Mortality following a probable or confirmed diagnosis in the community increased from an expected incidence of about 4.0% to actual incidence of 7.5%. In long-term care facilities, the corresponding increase was from 20.3% to 24.6%. The absolute increase was therefore similar at 3–4% in the community and in LTC residents. The percentage increase was far greater in the community (89.5%) than among patients in chronic care facilities (21.1%) who had higher baseline risk of mortality. The LTC population without probable or confirmed Covid-19 diagnoses experienced 38,932 excess deaths (34.8%) compared to historical estimates. Limitations in access to Covid-19 testing and disease under-reporting in LTC patients probably were important factors, although social isolation and disruption in usual care presumably also contributed. Remarkably, there were 31,360 (5.4%) fewer deaths than expected in community dwellers without probable or confirmed Covid-19 diagnoses. Disruptions to the healthcare system and avoided medical care were thus apparently offset by other factors, representing overall benefit. The Covid-19 pandemic had marked effects on mortality, but the effects were highly context-dependent. Public Library of Science 2022-02-02 /pmc/articles/PMC8809573/ /pubmed/35108291 http://dx.doi.org/10.1371/journal.pone.0262264 Text en © 2022 Greenwald et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Greenwald, Scott D.
Chamoun, Nassib G.
Manberg, Paul J.
Gray, Josh
Clain, David
Maheshwari, Kamal
Sessler, Daniel I.
Covid-19 and excess mortality in medicare beneficiaries
title Covid-19 and excess mortality in medicare beneficiaries
title_full Covid-19 and excess mortality in medicare beneficiaries
title_fullStr Covid-19 and excess mortality in medicare beneficiaries
title_full_unstemmed Covid-19 and excess mortality in medicare beneficiaries
title_short Covid-19 and excess mortality in medicare beneficiaries
title_sort covid-19 and excess mortality in medicare beneficiaries
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8809573/
https://www.ncbi.nlm.nih.gov/pubmed/35108291
http://dx.doi.org/10.1371/journal.pone.0262264
work_keys_str_mv AT greenwaldscottd covid19andexcessmortalityinmedicarebeneficiaries
AT chamounnassibg covid19andexcessmortalityinmedicarebeneficiaries
AT manbergpaulj covid19andexcessmortalityinmedicarebeneficiaries
AT grayjosh covid19andexcessmortalityinmedicarebeneficiaries
AT claindavid covid19andexcessmortalityinmedicarebeneficiaries
AT maheshwarikamal covid19andexcessmortalityinmedicarebeneficiaries
AT sesslerdanieli covid19andexcessmortalityinmedicarebeneficiaries